je.st
news
Gilead dodges billions in taxes as money rolls in from hepatitis C drugs
2015-02-26 23:21:38| Biotech - Topix.net
Gilead Sciences, whose $1,000-a-pill hepatitis C treatment is one of the world's most expensive drugs, is avoiding billions of dollars in U.S. taxes by booking profits overseas. The Foster City company reported foreign income before taxes of $8.2 billion for 2014, earning more in non-U.S. profits than it recorded in non-U.S. sales.
Tags: money
taxes
drugs
rolls
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||